Article
Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapy.
Annals of hepatology - 1 Jan 2000
Knop Viola, Teuber Gerlinde, Klinker Hartwig, Möller Bernd, Rasenack Jens, Hinrichsen Holger, Gerlach Tilman, Spengler Ulrich, Buggisch Peter, Neumann Konrad, Sarrazin Christoph, Zeuzem Stefan, Berg Thomas
Abstract excerpt
INTRODUCTION: Complete suppression of viral replication is crucial in chronic HCV treatment in order to prevent relapse and resistance development. We wanted to find out which factors influence the period from being already HCV RNA negative by bDNA assay (< 615 IU/mL) to become undetectable by the more sensitive TMA test (< 5.3 IU/mL). MATERIAL AND METHODS: Evaluated were 433 HCV type 1-infected patients. All of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.